Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$16.39 USD
-0.27 (-1.62%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $16.40 +0.01 (0.06%) 6:18 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
URGN 16.39 -0.27(-1.62%)
Will URGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for URGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for URGN
Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains?
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates
Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
Other News for URGN
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), AnaptysBio (ANAB) and Sarepta Therapeutics (SRPT)
Maintaining Neutral: Paul Choi’s Hold Rating on UroGen Pharma Amidst Steady Projections and Upcoming FDA Review
UroGen Pharma stock slumps after pricing stock and warrants offering
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
UroGen Pharma 5M share Spot Secondary priced at $17.50